-
Panama Government Expands List of Low-Cost Medications with Discounts of up to 95%
13 Jun 2025 15:03 GMT
… pharmaceuticals with significant discounts. There are now 110 pharmacies distributing affordable treatments … medications included in the low-cost access program, adding 80 new drugs … 100 mg, Enalapril 20 mg, Irbesartan 300 mg, Indapamide 1.5 …
-
9 Common Blood Pressure Medications and How They Work
10 Jun 2025 19:02 GMT
… Diuretics
Diuretics (water pills) increase the amount … )
Teveten (eprosartan)
Avapro (irbesartan)
Cozaar (losartan)
Benicar ( … Receptor Agonists
These drugs stimulate alpha-2 … Medications?
The extent of your high blood pressure helps determine which treatment …
-
Old Drugs, New Hope: Review Explores Repurposing Medicines for Rare Diseases
10 Jun 2025 09:03 GMT
… new drug development, treatment options remain severely limited.
In conversation with Medical … (ARBs) like losartan and irbesartan—typically prescribed for hypertension—in … governed clinical trials. If international regulatory bodies like the FDA or …
-
NICE Approves Sparsentan for Kidney Disease Treatment
28 May 2025 15:53 GMT
… effectively than standard treatment. The drug may also better … -controlled, phase 3 trial included patients aged 18 … irbesartan group.
The researchers concluded that treatment with sparsentan vs maximally titrated irbesartan … a retired NHS doctor. A well-known …
-
NICE relents and backs drug for IgAN from CSL Vifor
23 May 2025 12:24 GMT
… be eligible for treatment with the drug, which is … been shown in clinical trials to reduce levels of … treatment, which includes generic angiotensin-2 receptor blockers such as irbesartan … director of medicines evaluation, Helen Knight.
The drug will help …
-
England's NICE Recommends FILSPARI® (Sparsentan) As A Treatment Option For Iga Nephropathy
23 May 2025 08:49 GMT
… of diagnosis.11
Current medical treatment guidelines by KDIGO … , manufacturing and marketing pharmaceutical products for precision healthcare … , active-controlled clinical trial evaluating the safety and … for irbesartan-treated patients (n=202).4,17 Treatment …
-
FDA Accepts Sparsentan (Filspari) sNDA for Focal Segmental Glomerulosclerosis
15 May 2025 22:45 GMT
… , the FDA has assigned a Prescription Drug User Fee … daily, oral medication the first non-immunosuppressive treatment for preventing … consistent across all clinical trials conducted to date … active control, irbesartan, including no drug-induced liver injury …
-
Travere Therapeutics Announces FDA Acceptance of sNDA for FILSPARI® (sparsentan) in FSGS
15 May 2025 20:36 GMT
… treatment of focal segmental glomerulosclerosis (FSGS). The FDA has assigned a Prescription Drug … only non-immunosuppressive, oral medication that directly targets podocyte … maximally dosed irbesartan and consistent across all clinical trials conducted to …
-
Hypertension Clinical Trials And Studies 2025: EMA, PDMA, FDA Approvals, Mechanism Of Action, ROA, NDA, IND, And Companies
08 Apr 2025 00:36 GMT
… trials, emerging therapies, and leading companies with DelveInsight @ Hypertension Treatment Drugs
Hypertension Emerging Drugs … includes various innovative medicines aimed at treating … JW Pharmaceutical and others.
Hypertension Pipeline Therapies- Irbesartan…
-
Vanrafia, 2nd drug in Novartis' IgAN troika, crosses FDA finish line in payday for Chinook investors
03 Apr 2025 16:12 GMT
… biotech has submitted an application to the FDA to … trial called Protect.
Because the two meds feature different mechanisms, their trials … directly against the ARB drug irbesartan, Vanrafia was tested … typically eligible for novel treatments.
By comparison, …